Our faculty and staff conduct basic science, clinical, and outcomes research that covers a broad range of kidney disease including acute kidney injury and repair, glomerular diseases, cystic kidney disease, end-stage renal disease, and chronic kidney disease and related complications including diabetes, autoimmune disease, cardiovascular disease, and hypertension. The goal of all our research is to discover and develop new management and treatment options for patients with kidney disease, and to better educate our communities (regionally, nationally, and globally) on the risks and effects of kidney disease and how to prevent it.

Our research projects are supported by the NIH, foundation, and industry grants. Our division is also home to the George M. O'Brien Michigan Kidney Translational Core Center, which is funded by the National Institute of Diabetes and Digestive and Kidney Disease and just one of eight O’Brien Kidney Centers in the country.

In addition, many of our faculty members conduct research with the Kidney Epidemiology and Cost Center, Max Harry Weil Institute for Critical Care Research and InnovationInstitute for Healthcare Policy & Innovation, and Arbor Research Collaborative for Health, with several faculty members serving in leadership roles.

Michigan Medicine researchers from various disciplines discuss finding treatments and methods to prevent diabetic complications, including diabetic kidney disease, diabetic neuropathy, and diabetic retinopathy.